PANCREATIC INSUFFICIENCY
Clinical trials for PANCREATIC INSUFFICIENCY explained in plain language.
Never miss a new study
Get alerted when new PANCREATIC INSUFFICIENCY trials appear
Sign up with your email to follow new studies for PANCREATIC INSUFFICIENCY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a weekly shot delay diabetes in cystic fibrosis? new trial launches
Disease control Recruiting nowThis study tests whether a weekly injection of dulaglutide, a GLP-1 drug used for diabetes, can improve early insulin release in adults with cystic fibrosis who have trouble processing sugar. About 30 participants will receive the drug or no drug in a crossover design. The goal i…
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: PHASE2 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New drug trial aims to tackle diabetes in cystic fibrosis patients
Disease control Recruiting nowThis study tests a drug called dorzagliatin in 15 adults with cystic fibrosis who have trouble controlling their blood sugar. Participants take the drug or a placebo for 7 days each, in a crossover design. The goal is to see if dorzagliatin improves glucose tolerance and insulin …
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: PHASE1 • Sponsor: University of Pennsylvania • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Scientists probe gut hormones to unlock diabetes mystery in cystic fibrosis
Knowledge-focused Recruiting nowThis study aims to understand why many people with cystic fibrosis develop diabetes. Researchers will give two gut hormones, GLP-1 and GIP, to 45 adults with cystic fibrosis and measure how their pancreas releases insulin. The goal is to learn more about cystic fibrosis-related d…
Matched conditions: PANCREATIC INSUFFICIENCY
Phase: NA • Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC